Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 10.78 Amendment No. 3 to License Agreement, Dated As of December 19, 2008
- 10.79 Amendment No. 4 to License Agreement, Dated As of February 5, 2009
- 10.80 Directors Deferred Compensation Plan, As Amended
- 10.81 Amended and Restated Executive Change In Control and Severance Benefit Plan
- 10.82 Revision of Payment Terms of the Plea Agreement Dated As of July 17, 2007
- 10.83 Amendment to Settlement Agreement
- 12.1 Statement Re: Computation of Ratio of Earnings to Fixed Charges
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of Acting Pfo Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO & Acting Pfo Pursuant to 18 U.s.c. Section 1350
Related press release
JAZZ similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-143553 and 333-150008) pertaining to the 2003 Equity Incentive Plan, 2007 Equity Incentive Plan, 2007 Employee Stock Purchase Plan and 2007 Non-Employee Directors Stock Option Plan and the Registration Statements (Form S-3 Nos. 333-151593 and 333-151590) of Jazz Pharmaceuticals, Inc. and in the related Prospectuses of our report dated March 26, 2009, with respect to the consolidated financial statements and schedule of Jazz Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2008.
/s/ ERNST & YOUNG LLP |
Palo Alto, California |
March 26, 2009 |